Safety and Acceptance of COVID-19 Vaccination After Multisystem Inflammatory Syndrome in Children (MIS-C) in Spain

Authors:

Abstract
In this cohort of 42 adolescents with a previous multisystem inflammatory syndrome (MIS-C) diagnosis, 32 (76.2%) were vaccinated with COVID-19 vaccines, with a low incidence of relevant adverse events. More importantly, no new MIS-C or myocarditis occurred after a median of 10 weeks (range 5.3-19.7) post-vaccination.
Funding Information
  • Instituto de Salud Carlos III
  • European Regional Development Fund
  • Servicio Madrileño de Salud-Fundación para la Investigación Biomédica del Hospital 12 de Octubre (PI20/00095)
  • Spanish Ministry of Science and Innovation
  • Instituto de Salud Carlos III
  • Fondos Europeos de Desarrollo Regional (CM19/00015)
  • Asociación Española de Pediatría (COVID-19 EPICO-AEP 2020)

This publication has 2 references indexed in Scilit: